Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GeparSepto: nab-Paclitaxel vs Paclitaxel in Early Breast Cancer
NCT01583426Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Jul 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in breast cancer, sponsored by GBG Forschungs. Started Jul 2012; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01583426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01583426.